Comparison of Survival by Multimodal Treatment Regimen Among Malignant Pleural Mesothelioma Patients in an Integrated Health System

November 29, 2022 | Comments Off on Comparison of Survival by Multimodal Treatment Regimen Among Malignant Pleural Mesothelioma Patients in an Integrated Health System

Clinical Lung Cancer 2022 December [Link] Kian C Banks, Stephanie Ossowski, Yun-Yi Hung, Diana S Hsu, Simon K Ashiku, Ashish R Patel, Jeffrey B Velotta, J Marie Suga Abstract Background:…

Journey to the centre of the lung. The perspective of a mineralogist on the carcinogenic effects of mineral fibres in the lungs

November 28, 2022 | Comments Off on Journey to the centre of the lung. The perspective of a mineralogist on the carcinogenic effects of mineral fibres in the lungs

Journal of Hazardous Materials 2023 January 15 [Link] Alessandro F Gualtieri Abstract This work reviews the bio-chemical mechanisms leading to adverse effects produced when mineral fibres are inhaled and transported…

Emerging Role of Immunomonitoring to Predict the Clinical Outcome of Patients With Malignant Pleural Mesothelioma Treated With Radical Radiation Therapy

November 18, 2022 | Comments Off on Emerging Role of Immunomonitoring to Predict the Clinical Outcome of Patients With Malignant Pleural Mesothelioma Treated With Radical Radiation Therapy

International Journal of Radiation Oncology, Biology, Physics 2022 October 3 [Link] Michela Cangemi, Marcella Montico, Marco Trovo, Emilio Minatel, Emanuela Di Gregorio, Giuseppe Corona, Fabiana Giordari, Elisa Comaro, Francesca Colizzi,…

Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration

November 17, 2022 | Comments Off on Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration

Scientific Reports 2022 October 4 [Link] Kui Fan, Chuan-Long Zhang, Bo-Hui Zhang, Meng-Qi Gao, Yun-Chuan Sun Abstract Mesothelioma lies one of the most malignant tumors, in which the identification of…

Factors affecting the life expectancy in malignant pleural mesothelioma: Our 10 years of studies and experience

November 16, 2022 | Comments Off on Factors affecting the life expectancy in malignant pleural mesothelioma: Our 10 years of studies and experience

Medicine 2022 September 30 [Link] Filiz Cimen, Yetkin Agackiran, Sevim Düzgün, Melike Aloglu, Aysegül Senturk, Sükran Atikcan Abstract Malignant pleural mesothelioma (MPM) is an aggressive tumor with a poor prognosis.…

New candidates in the differential diagnosis of malignant mesothelioma from benign mesothelial hyperplasia and adenocarcinoma; DARS2 and suprabasin

November 15, 2022 | Comments Off on New candidates in the differential diagnosis of malignant mesothelioma from benign mesothelial hyperplasia and adenocarcinoma; DARS2 and suprabasin

Tissue & Cell 2022 September 6 [Link] Ozlem Ucer, Nevin Kocaman Abstract Objectives: Malignant mesothelioma (MM) is a primary malignant tumour with a very bad prognosis, which develops from the…

Butein-instigated miR-186-5p-dependent modulation of TWIST1 affects resistance to cisplatin and bioenergetics of Malignant Pleural Mesothelioma cells

November 14, 2022 | Comments Off on Butein-instigated miR-186-5p-dependent modulation of TWIST1 affects resistance to cisplatin and bioenergetics of Malignant Pleural Mesothelioma cells

Cancer Drug Resistance 2022 July 3 [Link] Mario Cioce, Daniela Rutigliano, Annamaria Puglielli, Vito Michele Fazio Abstract Aim: Malignant pleural mesothelioma is a chemoresistant tumor, and biphasic and sarcomatoid histologies…

Investigation of pd-l1 (cd274), pd-l2 (pdcd1lg2), and ctla-4 expressions in malignant pleural mesothelioma by immunohistochemistry and real-time polymerase chain reaction methods

October 28, 2022 | Comments Off on Investigation of pd-l1 (cd274), pd-l2 (pdcd1lg2), and ctla-4 expressions in malignant pleural mesothelioma by immunohistochemistry and real-time polymerase chain reaction methods

Polish Journal of Pathology 2022 October 6 [Link] Fatma Sule Kutlar Dursun, Ulas Alabalik Abstract Introduction: Malignant pleural mesothelioma (MPM) is an aggressive malignant disease with a poor prognosis, which…

Desmoid-type fibromatosis in the setting of malignant peritoneal mesothelioma: a case report of two rare diseases

October 27, 2022 | Comments Off on Desmoid-type fibromatosis in the setting of malignant peritoneal mesothelioma: a case report of two rare diseases

World Journal of Surgical Oncology 2022 September 28 [Link] Stephanie N Gregory, Audra A Satterwhite, H Richard Alexander, Andrew M Blakely Abstract Background: Desmoid-type fibromatosis (DTF) is a rare benign…

Immunotherapy combined with antiangiogenic agents in patients with advanced malignant pleural mesothelioma: A case report

October 26, 2022 | Comments Off on Immunotherapy combined with antiangiogenic agents in patients with advanced malignant pleural mesothelioma: A case report

World Journal of Clinical Cases 2022 August 16 [Link] Tian-Tian Xuan, Guang-Yi Li, Si-Bo Meng, Zhan-Mei Wang, Lin-Li Qu Abstract Background: Malignant pleural mesothelioma has limited therapeutic options and a…

Categories